BANK OF AMERICA CORP /DE/ - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$30,851,538
-28.5%
679,699
-11.5%
0.00%
-25.0%
Q2 2023$43,124,334
+84.2%
768,157
+48.4%
0.00%
+100.0%
Q1 2023$23,415,843
+35.1%
517,706
+21.4%
0.00%0.0%
Q4 2022$17,337,876
-87.7%
426,516
-80.2%
0.00%
-87.5%
Q3 2022$140,436,000
+35.1%
2,148,982
+25.6%
0.02%
+45.5%
Q2 2022$103,942,000
+128.1%
1,710,412
+135.6%
0.01%
+175.0%
Q1 2022$45,575,000
-18.1%
726,049
-1.2%
0.00%
-20.0%
Q4 2021$55,668,000
-66.9%
734,610
-51.1%
0.01%
-72.2%
Q3 2021$168,048,000
-3.4%
1,501,373
+39.8%
0.02%0.0%
Q2 2021$173,886,000
+215.2%
1,074,098
+137.2%
0.02%
+200.0%
Q1 2021$55,170,000
+2.5%
452,767
+28.8%
0.01%
-14.3%
Q4 2020$53,837,000
+809.6%
351,630
+396.9%
0.01%
+600.0%
Q3 2020$5,919,000
+2.8%
70,771
-9.6%
0.00%0.0%
Q2 2020$5,755,000
+116.4%
78,301
+24.9%
0.00%
Q1 2020$2,659,000
-7.7%
62,682
+32.5%
0.00%
Q4 2019$2,880,000
-9.4%
47,292
-39.0%
0.00%
Q3 2019$3,180,000
+304.6%
77,576
+365.0%
0.00%
Q2 2019$786,000
-37.5%
16,683
-52.6%
0.00%
Q1 2019$1,257,000
+666.5%
35,165
+514.9%
0.00%
Q4 2018$164,000
-53.3%
5,719
-27.4%
0.00%
Q3 2018$351,000
-36.5%
7,879
-16.2%
0.00%
Q2 2018$553,000
+62.6%
9,407
+26.5%
0.00%
Q1 2018$340,000
+44.7%
7,435
-25.9%
0.00%
Q4 2017$235,000
+5.4%
10,029
-19.5%
0.00%
Q3 2017$223,000
+12.1%
12,4620.0%0.00%
Q2 2017$199,000
-37.0%
12,462
-14.1%
0.00%
Q1 2017$316,000
-27.5%
14,512
-32.5%
0.00%
Q4 2016$436,00021,5000.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q2 2022
NameSharesValueWeighting ↓
Gilfoyle Management LLC 150$6,37612.96%
Versant Venture Management, LLC 498,558$22,629,54812.03%
NEA Management Company, LLC 1,587,854$72,072,6935.57%
ARK Investment Management 7,163,118$325,133,9132.49%
Nikko Asset Management Americas, Inc. 3,465,470$157,263,0291.88%
Integral Health Asset Management, LLC 275,000$12,482,2501.73%
Merlin Capital, Inc 9,092$412,6861.54%
Del-Sette Capital Management, LLC 33,977$1,542,2161.52%
Green Alpha Advisors, LLC 34,880$1,583,2031.22%
Ikarian Capital, LLC 2,039$9,255,0211.11%
View complete list of CRISPR THERAPEUTICS AG shareholders